Free Trial

BioCryst Pharmaceuticals (BCRX) SEC Filings & 10K Form

BioCryst Pharmaceuticals logo
$11.00 +0.44 (+4.12%)
As of 03:44 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent BioCryst Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/15/2025
8:31 AM
Avoro Capital Advisors LLC (Filed by)
BioCryst Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
05/14/2025
6:16 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
3:31 PM
BioCryst Pharmaceuticals (Issuer)
Frank Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
6:11 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
6:14 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2025
3:02 PM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
5:26 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
7:01 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
6:09 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
6:13 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
6:20 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
3:19 PM
BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:11 PM
BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:01 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:05 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:16 PM
BioCryst Pharmaceuticals (Issuer)
Stonehouse Jon P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:22 PM
BioCryst Pharmaceuticals (Issuer)
Gayer Charles K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:10 PM
Barnes Alane P (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:03 PM
BioCryst Pharmaceuticals (Issuer)
Thackray Helen M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:06 PM
BioCryst Pharmaceuticals (Issuer)
Doyle Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:35 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
3:23 PM
BioCryst Pharmaceuticals (Subject)
Hutson Nancy J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:06 PM
BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
9:52 AM
BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/07/2024
9:25 AM
BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/05/2024
4:19 PM
BioCryst Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
10:18 AM
BioCryst Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
10:52 AM
BioCryst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/02/2024
6:06 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
6:11 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
11:09 AM
BioCryst Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
08/05/2024
6:05 AM
BioCryst Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:39 PM
BioCryst Pharmaceuticals (Issuer)
McKee Amy E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
3:31 PM
BioCryst Pharmaceuticals (Issuer)
SANDERS MACHELLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:27 PM
BioCryst Pharmaceuticals (Issuer)
Hutson Nancy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:28 PM
BioCryst Pharmaceuticals (Issuer)
LEVIN ALAN G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:30 PM
BioCryst Pharmaceuticals (Issuer)
McKee Amy E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:31 PM
BioCryst Pharmaceuticals (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:33 PM
BioCryst Pharmaceuticals (Issuer)
SANDERS MACHELLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Elon just did WHAT!? (Ad)

As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.

Click here to see how to claim your stake before they launch to avoid missing out.
06/14/2024
3:18 PM
ABERCROMBIE GEORGE B (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:20 PM
ASELAGE STEVE (Reporting)
BioCryst Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:23 PM
BioCryst Pharmaceuticals (Issuer)
Galson Steven K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:33 PM
BioCryst Pharmaceuticals (Issuer)
HEGGIE THERESA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BCRX) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners